KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutanix (NTNX) Depreciation and Depletion: 2015-2025

Historic Depreciation and Depletion for Nutanix (NTNX) over the last 5 years, with Oct 2025 value amounting to $17.1 million.

  • Nutanix's Depreciation and Depletion rose 4.27% to $17.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $67.0 million, marking a year-over-year increase of 1.67%. This contributed to the annual value of $66.3 million for FY2025, which is 1.07% up from last year.
  • As of Q4 2025, Nutanix's Depreciation and Depletion stood at $17.1 million, which was down 0.00% from $17.1 million recorded in Q3 2025.
  • In the past 5 years, Nutanix's Depreciation and Depletion ranged from a high of $19.2 million in Q1 2021 and a low of $15.5 million during Q3 2023.
  • Moreover, its 3-year median value for Depreciation and Depletion was $16.4 million (2025), whereas its average is $16.4 million.
  • In the last 5 years, Nutanix's Depreciation and Depletion fell by 15.26% in 2022 and then increased by 5.81% in 2024.
  • Nutanix's Depreciation and Depletion (Quarterly) stood at $18.7 million in 2021, then dropped by 14.44% to $16.0 million in 2022, then rose by 0.63% to $16.1 million in 2023, then grew by 1.86% to $16.4 million in 2024, then increased by 4.27% to $17.1 million in 2025.
  • Its Depreciation and Depletion was $17.1 million in Q4 2025, compared to $17.1 million in Q3 2025 and $16.4 million in Q2 2025.